Kidney News and Research

RSS

Researchers identify gene responsible for Meckel-Gruber and Joubert syndromes

An international group of researchers has identified the genetic cause of an inherited condition that causes severe foetal abnormalities.

31 May 2010

Misonix announces sale of all rights to HIFU technology, HIFU related assets to USHIFU

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which is used in Europe for the ablation of tumors and worldwide for acute health conditions, today announced the sale to USHIFU, LLC of all of the rights to the High Intensity Focused Ultrasound technology previously obtained from Focus Surgery, Inc., a wholly owned subsidiary of USHIFU, together with other HIFU related assets.

29 May 2010

Sunitinib not effective in patients with papillary RCC: Researchers

Of the more than 38,000 Americans diagnosed with renal cell carcinoma each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently to sunitinib - a standard frontline treatment for RCC.

29 May 2010

MU awarded $6.8M to help patients benefit from use of health information technology

Considered one the great advances of modern medicine, electronic health records can provide a patient's entire medical history and a wealth of other information at the click of a button. They also have the potential to save countless lives and billions of dollars. Now, the University of Missouri has a two-year, $6.8 million cooperative agreement to help patients throughout the state benefit from increased use of this health information technology.

29 May 2010

DaVita provides hurricane hotline to help dialysis patients find clinics, schedule treatments during emergencies

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease, announced today that the company will provide a hurricane hotline (1-800-400-8331) that is activated 24 hours a day, seven days a week to help dialysis patients find open clinics and schedule treatments during emergencies such as hurricanes and other natural disasters.

28 May 2010

Consistent consumption of alcohol contributes to high blood pressure

High blood pressure is a leading cause of deaths in the world. Apart from millions with diagnosed hypertension, still many others are borderline hypertensive. High blood pressure increases the risk of a person to develop cardiovascular diseases, kidney problems, heart attack and even a stroke. One of the major contributors to high blood pressure is the consistent consumption of alcohol. Regular alcohol drinkers increase the risks of elevated blood pressure because it affects the normal functioning of the body by reversing what it needs to remain healthy.

28 May 2010

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

A new public-private partnership between AstraZeneca and NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will focus on supporting the work of the Drug-Induced Liver Injury Network (DILIN). DILIN is a group working to bring together essential scientific and financial resources to better understand drug-induce liver injury as well as effective screening, diagnostic and treatment options.

28 May 2010

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

Nephrologists must consider fluid overload effects when prescribing dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology. The fluid overload biomarker, N-terminal pro-brain-type natriuretic peptide, previously known as a "cardiac biomarker" in dialysis patients, is an important component of managing patients with kidney disease.

28 May 2010

BTE awards Diabetes Care Recognition Program certificates to 118 Montefiore Medical Group physicians

Bridges to Excellence, a national program that recognizes and rewards physicians for delivering better quality care, today awarded its sought-after Diabetes Care Recognition Program certificate to the 118 physicians in Montefiore Medical Center's 20 outpatient care facilities, known as the Montefiore Medical Group, for substantially lowering blood sugar levels and "bad" cholesterol levels in thousands of adult patients with diabetes.

28 May 2010

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

The disease-causing bacterium E. coli O157:H7 is present but rare in some wildlife species of California's agriculturally rich Central Coast region, an area often referred to as the nation's "salad bowl," reports a team or researchers led by a UC Davis scientist.

28 May 2010

Restricting salt intake helps control blood pressure in dialysis patients: Research

For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

28 May 2010

IOM, UIC to convene regional meeting to discuss rising rates of diabetes, obesity in the U.S

The Institute of Medicine of the National Academies will convene a regional meeting on Sept. 21 at the University of Illinois at Chicago to discuss the rapidly rising rates of diabetes and obesity in the U.S.

27 May 2010

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Weill Cornell Medical College today celebrated the start of construction on its new Medical Research Building, a state-of-the-art facility that will more than double the institution's existing research space. The 18-story, $650 million building is the centerpiece of Weill Cornell's $1.3 billion Discoveries that Make a Difference Campaign, the country's largest for a medical college. A total of $1 billion has been raised toward this goal in a record time of less than four years.

27 May 2010

Health Canada approves Victoza for treatment of adults with type 2 diabetes

Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.

27 May 2010

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $9.5 million grant for the continuation of its Diabetes Research and Training Center (DRTC). The DRTC was also awarded a $632,000 supplemental grant for equipment and additional pilot and feasibility studies through the American Recovery and Reinvestment Act (ARRA), bringing total NIH support to $10,177,000.

26 May 2010

CMS approves Fresenius Medical Care Chronic Kidney Disease Data Registry

The U.S. Centers for Medicare and Medicaid Services (CMS) approved the Fresenius Medical Care Chronic Kidney Disease Data Registry, supported by its Acumen applications. As a participating registry in CMS's 2010 Physician Quality Reporting Initiative (PQRI), the approval of the nephrology-specific Acumen applications enables participating nephrologists to report quality outcomes directly to the PQRI program.

26 May 2010

NASH-induced cirrhosis is greater risk factor for HCC: Cleveland Clinic study

A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting from hepatitis C virus. Results of this study appear in the June issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

26 May 2010

Kidney Health Week, experts criticise government inaction

Kidney Health Week is being observed at Broken Hill Hospital this week by the Broken Hill Health Service. As a part of this the residents will receive complete kidney check ups including blood pressure and blood sugar and advice regarding kidney health.

26 May 2010

Genzyme's suit stays final FDA approval of Watson's generic Renvela ANDA

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market sevelamer carbonate 800mg tablets. Watson's sevelamer carbonate tablet is the generic version of Genzyme's Renvela®. Renvela ® is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease who are on dialysis.

26 May 2010

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.

25 May 2010

Kidney News and Research

Researchers identify gene responsible for Meckel-Gruber and Joubert syndromes

Misonix announces sale of all rights to HIFU technology, HIFU related assets to USHIFU

Sunitinib not effective in patients with papillary RCC: Researchers

MU awarded $6.8M to help patients benefit from use of health information technology

DaVita provides hurricane hotline to help dialysis patients find clinics, schedule treatments during emergencies

Consistent consumption of alcohol contributes to high blood pressure

AstraZeneca, NIDDK partnership to support Drug-Induced Liver Injury Network

Cardiac biomarkers help nephrologists manage fluid overload in dialysis patients: Study

BTE awards Diabetes Care Recognition Program certificates to 118 Montefiore Medical Group physicians

E. coli O157:H7 is rare in some wildlife species of California's Central Coast region: Researchers

Restricting salt intake helps control blood pressure in dialysis patients: Research

IOM, UIC to convene regional meeting to discuss rising rates of diabetes, obesity in the U.S

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Health Canada approves Victoza for treatment of adults with type 2 diabetes

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

CMS approves Fresenius Medical Care Chronic Kidney Disease Data Registry

NASH-induced cirrhosis is greater risk factor for HCC: Cleveland Clinic study

Kidney Health Week, experts criticise government inaction

Genzyme's suit stays final FDA approval of Watson's generic Renvela ANDA

Rockwell Medical's SFP Phase IIb data accepted for presentation at XLVII ERA-EDTA Congress

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News